| abstract |
In particular, the present invention provides pyrazolyl-substituted pyridone compounds that exhibit biological activity, such as inhibition, against serine proteases, including thrombin and various kallikreins. Pharmaceutical compositions are also provided. Also provided are methods of treating and preventing certain diseases or conditions amenable to treatment or prevention by inhibition of serine proteases, including thrombin and various kallikreins. |